FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to surgery, hepatology, oncology, and can be used for combined treatment of unresectable cancer of extrahepatic bile ducts. That is ensured by systemic chemotherapy courses using platinum, fluorouracil or gemcitabine preparations. That is combined with high-intensity focused ultrasonic therapy with average acoustic power of 400–600 W, 4 sessions per course, 1 session a day, except intravenous days of chemopreparations.
EFFECT: method provides more effective systemic chemotherapy with minimizing the frequency of developing complications of treatment, increasing the total and recurrence-free survival.
1 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR THE TREATMENT OF UNRESECTABLE HYLUS CHOLANGIOCARCINOMA | 2020 |
|
RU2755329C2 |
| METHOD FOR PHOTODYNAMIC THERAPY IN THE TREATMENT OF UNRESECTABLE ADENOCARCINOMA OF EXTRAHEPATIC BILE DUCTS | 2020 |
|
RU2753402C1 |
| METHOD OF REDUCTION OF THE EXPRESSION OF CHRONIC PAIN SYNDROME IN PATIENTS WITH PANCREATIC CANCER WITH FUNCTIONAL STATUS ECOG 0-2 POINTS | 2022 |
|
RU2793519C2 |
| METHOD OF COMBINED TREATMENT OF PATIENTS WITH PRIMARILY OPERABLE AND LOCALLY ADVANCED INOPERABLE BREAST CANCER | 2017 |
|
RU2664597C1 |
| METHOD OF TREATING UNRESECTABLE BILIARY TRACT CANCER | 2008 |
|
RU2377004C1 |
| METHOD OF TREATING NONRESECTABLE AND POTENTIALLY RESECTABLE METASTASES OF COLORECTAL CANCER IN LIVER | 2019 |
|
RU2722349C2 |
| METHOD FOR TREATMENT OF REGIONAL UNRESECTABLE PANCREATIC CANCER | 2017 |
|
RU2663468C1 |
| METHOD OF PERCUTANEOUS TRANSHEPATIC PLUCK INTRADUCTAL BIOPSY | 2022 |
|
RU2798679C1 |
| METHOD FOR DETERMINING SURVIVAL OF PATIENTS WITH INTRAHEPAPER CHOLANGIOCELLULAR CANCER IN THE POSTOPERATIVE PERIOD | 2021 |
|
RU2773252C1 |
| METHOD OF COMBINED TREATMENT OF MUSCULO-INVASIVE BLADDER CANCER T3-T4 N0-+M0 | 2019 |
|
RU2713443C2 |
